Table 2 Characteristics of IPMN patients stratified by CA125
Variables | CA125 ≤ 13.4 U/ml | CA125 > 13.4 U/ml | p-Value |
|---|---|---|---|
Age, n(%),y | Â | Â | 0.940 |
 < 60 | 82 (32.4%) | 41 (32.0%) |  |
 ≥ 60 | 171 (67.6%) | 87 (68.0%) |  |
Sex, (n%) | Â | Â | 0.043 |
 Male | 152 (60.1%) | 63 (49.2%) |  |
 Female | 101 (39.9%) | 65 (50.8%) |  |
Location, (n%) | Â | Â | 0.324 |
 Head | 147 (63.9%) | 81 (69.2%) |  |
 Body and tail | 83 (36.1%) | 36 (30.8%) |  |
Tumour grade, (n%) | Â | Â | < 0.001 |
 Low and moderate | 180 (71.1%) | 66 (51.6%) |  |
 High and carcinoma | 73 (28.9%) | 62 (48.4%) |  |
Vascular invasion, (n%) | Â | Â | 0.335 |
 No | 125 (98.4%) | 60 (95.2%) |  |
 Yes | 2 (1.6%) | 3 (4.8%) |  |
Perineural infiltration, (n%) | Â | Â | 0.510 |
 No | 121 (95.3%) | 58 (92.1%) |  |
 Yes | 6 (4.7%) | 5 (7.9%) |  |
Ductal dilation, (n%) | Â | Â | 0.013 |
 No | 175 (69.2%) | 72 (56.3%) |  |
 Yes | 78 (30.8%) | 56 (43.8%) |  |